256 related articles for article (PubMed ID: 17049666)
1. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
2. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study.
Zhang LZ; Zhang TC; Pan FM; Zhang ZH; Li X
Arch Virol; 2010 Nov; 155(11):1839-42. PubMed ID: 20661604
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
[TBL] [Abstract][Full Text] [Related]
5. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
[TBL] [Abstract][Full Text] [Related]
7. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients.
Paradowska-Gorycka A; Trefler J; Maciejewska-Stelmach J; Łacki JK
Int J Immunogenet; 2010 Aug; 37(4):225-31. PubMed ID: 20477882
[TBL] [Abstract][Full Text] [Related]
9. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection.
Zhu C; Zhang R; Liu D; Mukhtar MM; Liu W; Peng G; Wang K; Hao Q; Xu Y; Liu F; Zhu Y; Wu J
Clin Chim Acta; 2009 Mar; 401(1-2):124-7. PubMed ID: 19083997
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
Fabris M; Quartuccio L; Salvin S; Pozzato G; De Re V; Mazzaro C; Ferri C; Baldini C; De Vita S
Ann Rheum Dis; 2008 Jan; 67(1):80-3. PubMed ID: 17526550
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
Bouzgarrou N; Hassen E; Farhat K; Bahri O; Gabbouj S; Maamouri N; Ben Mami N; Saffar H; Trabelsi A; Triki H; Chouchane L
Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt.
Cowgill KD; Loffredo CA; Eissa SA; Mokhtar N; Abdel-Hamid M; Fahmy A; Strickland GT
Int J Epidemiol; 2004 Oct; 33(5):1034-9. PubMed ID: 15155696
[TBL] [Abstract][Full Text] [Related]
15. [Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China].
Gao Q; Zhang S; Wu L; Jia M; Mi Y; Liu D
Wei Sheng Yan Jiu; 2011 Nov; 40(6):709-13. PubMed ID: 22279662
[TBL] [Abstract][Full Text] [Related]
16. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
17. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
[TBL] [Abstract][Full Text] [Related]
20. Relationship between IL-10 gene -1082A/G and -592C/A polymorphisms and the risk of hepatitis C infection: a meta-analysis.
Sun XR; Wu J; Shi KQ; Tang KF
J Viral Hepat; 2013 Sep; 20(9):602-11. PubMed ID: 23910644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
